申请人:Eli Lilly and Company
公开号:US05834488A1
公开(公告)日:1998-11-10
The invention provides dihydrobenzo\x9bb!indenothiophene compounds, intermediates, processes, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.
这项发明提供了二氢苯并[9,10-b]噻吩化合物、中间体、工艺、配方和抑制骨质流失或骨吸收的方法,特别是对于骨质疏松症、与心血管相关的病理条件,包括高脂血症和相关心血管病理以及雌激素依赖性癌症。